1. Home
  2. EDSA vs SMX Comparison

EDSA vs SMX Comparison

Compare EDSA & SMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SMX
  • Stock Information
  • Founded
  • EDSA 2015
  • SMX N/A
  • Country
  • EDSA Canada
  • SMX Ireland
  • Employees
  • EDSA N/A
  • SMX N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SMX Industrial Machinery/Components
  • Sector
  • EDSA Health Care
  • SMX Technology
  • Exchange
  • EDSA Nasdaq
  • SMX Nasdaq
  • Market Cap
  • EDSA 17.5M
  • SMX 19.2M
  • IPO Year
  • EDSA N/A
  • SMX N/A
  • Fundamental
  • Price
  • EDSA $2.72
  • SMX $1.30
  • Analyst Decision
  • EDSA Strong Buy
  • SMX
  • Analyst Count
  • EDSA 2
  • SMX 0
  • Target Price
  • EDSA $13.00
  • SMX N/A
  • AVG Volume (30 Days)
  • EDSA 121.9K
  • SMX 3.3M
  • Earning Date
  • EDSA 08-08-2025
  • SMX 01-01-0001
  • Dividend Yield
  • EDSA N/A
  • SMX N/A
  • EPS Growth
  • EDSA N/A
  • SMX N/A
  • EPS
  • EDSA N/A
  • SMX N/A
  • Revenue
  • EDSA N/A
  • SMX N/A
  • Revenue This Year
  • EDSA N/A
  • SMX N/A
  • Revenue Next Year
  • EDSA N/A
  • SMX N/A
  • P/E Ratio
  • EDSA N/A
  • SMX N/A
  • Revenue Growth
  • EDSA N/A
  • SMX N/A
  • 52 Week Low
  • EDSA $1.55
  • SMX $1.10
  • 52 Week High
  • EDSA $4.49
  • SMX $2,296.30
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 62.87
  • SMX 40.53
  • Support Level
  • EDSA $2.47
  • SMX $1.22
  • Resistance Level
  • EDSA $2.82
  • SMX $1.41
  • Average True Range (ATR)
  • EDSA 0.18
  • SMX 0.17
  • MACD
  • EDSA 0.03
  • SMX 0.07
  • Stochastic Oscillator
  • EDSA 85.46
  • SMX 21.74

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

Share on Social Networks: